Alethia Biotherapeutics

Alethia Biotherapeutics is a biotech company in Montreal, Canada, founded in 2002. It has raised $16.5M across 5 rounds, most recently a Series C in October 2024.

Re-engineering the tumor microenvironment to overcome immune suppression

Headquarters
Montreal, Quebec
Employees
11–50
Founded
2002
Business Model
B2B
Total Funding
$16.5M
Last Round
Series COct 2024
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 1 investor for this company. The full record is or through the API.

About

Alethia Biotherapeutics is a privately held, Montreal-based clinical-stage biotechnology company founded in 2002. The company is engaged in the discovery and development of therapeutic monoclonal antibodies against novel, clinically relevant targets in cancer and inflammatory diseases, with a focus on cancer-associated epithelial-to-mesenchymal transition (EMT) pathways.

Summary

It lists 11–50 employees. It has raised $16.5M in total across 5 rounds, most recently a Series C round in Oct 2024. Investors include BDC Venture Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries COct 2024

Sign up to see all 5 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alethia Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alethia-biotherapeutics"><img src="https://indexed.vc/api/badge/company/alethia-biotherapeutics" alt="Alethia Biotherapeutics on Indexed.vc" width="260" height="76" /></a>